ANTI-CRO LINDUS HEALTH RAISES $55M IN SERIES B FUNDING TO TRANSFORM THE CLINICAL TRIAL LANDSCAPE
LINDUS HEALTH - ROUND WAS LED BY NEW INVESTOR BALDERTON CAPITAL, WITH SUPPORT FROM VISIONARIES CLUB
Source text: ID:nPn7rv1k4a
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.